-
1 Comment
Ortin Laboratories Limited is currently in a long term downtrend where the price is trading 3.7% below its 200 day moving average.
From a valuation standpoint, the stock is 97.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.1.
Ortin Laboratories Limited's total revenue sank by 4.4% to $518M since the same quarter in the previous year.
Its net income has increased by 134.6% to $6M since the same quarter in the previous year.
Finally, its free cash flow fell by 15.0% to $19M since the same quarter in the previous year.
Based on the above factors, Ortin Laboratories Limited gets an overall score of 2/5.
| Industry | Drug Manufacturers - Specialty & Generic |
|---|---|
| Sector | Healthcare |
| Exchange | NSE |
| ISIN | INE749B01012 |
| CurrencyCode | INR |
| Beta | 1.43 |
|---|---|
| Market Cap | 132M |
| PE Ratio | 11.39 |
| Target Price | None |
| Dividend Yield | 0.0% |
Ortin Laboratories Limited manufactures and trades in pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti biotics-quinolones, anti biotic-pencillins, cephalosporins, and macrolides; and anti anginal and cardio vascular, and antifungal products. The company's formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium preparations, iron preparations, anti arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti retroviral products. In addition, it provides active pharmaceutical ingredient (API) intermediates comprising anti retro viral, anti diabetics, analgesics and antipyretics, anti biotic, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company offers services in the areas of process development, process characterization, analytical research and development, assay development, and product characterization; and diagnostic services, including development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. Ortin Laboratories Limited was founded in 1986 and is based in Hyderabad, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ORTINLABSS.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
